Ureteral Stent Placement Increases the Risk for Developing BK Viremia after Kidney Transplantation

Abstract EN

The placement of ureteral stent (UrSt) at kidney transplantation reduces major urological complications but increases the risk for developing nephropathy from the BK virus.

It is unclear whether UrSt placement increases nephropathy risk by increasing risk of precursor viral replication or by other mechanisms.

We retrospectively investigated whether UrSt placement increased the risk for developing BK Viremia (BKVM) in adult and pediatric kidney transplants performed at the University of Florida between July 1, 2007, and December 31, 2010.

In this period all recipients underwent prospective BKV PCR monitoring and were maintained on similar immunosuppression.

Stent placement or not was based on surgeon preference.

In 621 transplants, UrSt were placed in 295 (47.5%).

BKVM was seen in 22% versus 16% without UrSt ( P = 0.05 ).

In multivariate analyses, adjusting for multiple transplant covariates, only UrSt placement remained significantly associated with BKVM ( P = 0.04 ).

UrSt placement significantly increased the risk for BKVM.

Routine UrSt placement needs to be revaluated, since benefits may be negated by the need for more BK PCR testing and potential for graft survival-affecting nephritis.